Xenocor offers a suite of leading edge, fog-free, single-use endoscopes for minimally invasive surgical procedures.
Xenocor has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in April 2023.
Xenocor's investors include Mountain Pacific Partners, GenHenn Venture, Growing Impact Ventures, Baranco, Patel Family Investment.
Xenocor is headquartered in Salt Lake City, United States.
Xenocor offers a suite of leading edge, fog-free, single-use endoscopes for minimally invasive surgical procedures.
Xenocor is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xenocor — Funding & Investors." VCBacked, April 18, 2023, https://www.vcbacked.co/company/xenocor. Accessed October 29, 2026.
VCBacked. (2023). Xenocor — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/xenocor
{{cite web |title=Xenocor — Funding & Investors |url=https://www.vcbacked.co/company/xenocor |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated